Asuragen is a biotechnology company that leverages genetics for molecular diagnostics, with exceptionally strong R&D and innovation capabilities, particularly in miRNA therapeutics and molecular diagnostics where it holds an advanced position. Asuragen integrates the exploration of cutting-edge technologies, the development of commercial diagnostic reagents, and the provision of clinical trial services. The company rapidly and effectively addresses both current and emerging clinical needs — including cancer diagnostics and monitoring, reproductive health, and aging — and provides laboratory services across the entire patient lifecycle through diagnostic testing.

Asuragen's development philosophy is "discover, develop, diagnose." This refers to discovering novel disease biomarkers, developing highly specific detection methods based on the characteristics of these biomarkers, and providing practical reference value to enable physicians to make accurate clinical diagnoses.